Histone Modifications Are Associated with Δ9-Tetrahydrocannabinol-mediated Alterations in Antigen-specific T Cell Responses*
暂无分享,去创建一个
[1] Pritesh Kumar,et al. CB2 cannabinoid receptor is a novel target for third-generation selective estrogen receptor modulators bazedoxifene and lasofoxifene. , 2014, Biochemical and biophysical research communications.
[2] P. Prather,et al. CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen. , 2013, Biochemical and biophysical research communications.
[3] M. Nagarkatti,et al. Distinct MicroRNA Expression Profile and Targeted Biological Pathways in Functional Myeloid-derived Suppressor Cells Induced by Δ9-Tetrahydrocannabinol in Vivo , 2013, The Journal of Biological Chemistry.
[4] Z. Vogel,et al. Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype , 2013, Journal of Neuroimmune Pharmacology.
[5] J. Reményi,et al. miR-132/212 Knockout Mice Reveal Roles for These miRNAs in Regulating Cortical Synaptic Transmission and Plasticity , 2013, PloS one.
[6] Yan Liu,et al. Akt kinase targets the association of CBP with histone H3 to regulate the acetylation of lysine K18 , 2013, FEBS letters.
[7] J. Mattick,et al. Structure and function of long noncoding RNAs in epigenetic regulation , 2013, Nature Structural &Molecular Biology.
[8] N. Kaminski,et al. Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[9] H. Kimura,et al. H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells , 2012, BMC Genomics.
[10] A. Schier,et al. Bivalent histone modifications in early embryogenesis. , 2012, Current opinion in cell biology.
[11] E. Greer,et al. Histone methylation: a dynamic mark in health, disease and inheritance , 2012, Nature Reviews Genetics.
[12] B. Todaro. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.
[13] L. Zitvogel,et al. Inflammasomes in carcinogenesis and anticancer immune responses , 2012, Nature Immunology.
[14] M. van Beurden,et al. An autoimmune phenotype in vulvar lichen sclerosus and lichen planus: a Th1 response and high levels of microRNA-155. , 2012, The Journal of investigative dermatology.
[15] I. Ellis,et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer , 2011, Nature.
[16] M. Nagarkatti,et al. Perinatal Exposure to Δ9-Tetrahydrocannabinol Triggers Profound Defects in T Cell Differentiation and Function in Fetal and Postnatal Stages of Life, Including Decreased Responsiveness to HIV Antigens , 2011, Journal of Pharmacology and Experimental Therapeutics.
[17] M. Nagarkatti,et al. Targeting Cannabinoid Receptors as a Novel Approach in the Treatment of Graft-versus-Host Disease: Evidence from an Experimental Murine Model , 2011, Journal of Pharmacology and Experimental Therapeutics.
[18] Clifford A. Meyer,et al. Cistrome: an integrative platform for transcriptional regulation studies , 2011, Genome Biology.
[19] T. Mak,et al. Histone Demethylase JMJD2B Functions as a Co-Factor of Estrogen Receptor in Breast Cancer Proliferation and Mammary Gland Development , 2011, PloS one.
[20] M. Nagarkatti,et al. Cannabinoid receptor activation leads to massive mobilization of myeloid‐derived suppressor cells with potent immunosuppressive properties , 2010, European journal of immunology.
[21] Ryan M. O’Connell,et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. , 2010, Immunity.
[22] L. Altucci,et al. Cannabinoid receptor 1 influences chromatin remodeling in mouse spermatids by affecting content of transition protein 2 mRNA and histone displacement. , 2010, Endocrinology.
[23] Mariarosaria Incoronato,et al. miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. , 2010, Cancer research.
[24] Frances Gotch,et al. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator , 2010, Nature Cell Biology.
[25] Daniel J. Blankenberg,et al. Galaxy: A Web‐Based Genome Analysis Tool for Experimentalists , 2010, Current protocols in molecular biology.
[26] H. Soreq,et al. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. , 2009, Immunity.
[27] S. Cinti. Medical Marijuana in HIV-Positive Patients: What Do We Know? , 2009, Journal of the International Association of Physicians in AIDS Care.
[28] M. Nagarkatti,et al. Cannabinoids as novel anti-inflammatory drugs. , 2009, Future medicinal chemistry.
[29] M. F. Shannon,et al. Defining the chromatin signature of inducible genes in T cells , 2009, Genome Biology.
[30] Dustin E. Schones,et al. A clustering approach for identification of enriched domains from histone modification ChIP-Seq data , 2009, Bioinform..
[31] Dustin E. Schones,et al. Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. , 2009, Immunity.
[32] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[33] Yuka Kanno,et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. , 2009, Immunity.
[34] T. Proft,et al. The bacterial superantigen and superantigen‐like proteins , 2008, Immunological reviews.
[35] Michael Q. Zhang,et al. Combinatorial patterns of histone acetylations and methylations in the human genome , 2008, Nature Genetics.
[36] M. Nagarkatti,et al. Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells , 2008, Molecular Pharmacology.
[37] M. Maccarrone,et al. Anandamide Regulates Keratinocyte Differentiation by Inducing DNA Methylation in a CB1 Receptor-dependent Manner* , 2008, Journal of Biological Chemistry.
[38] C. Paraskeva,et al. The cannabinoid δ9‐tetrahydrocannabinol inhibits RAS‐MAPK and PI3K‐AKT survival signalling and induces BAD‐mediated apoptosis in colorectal cancer cells , 2007 .
[39] T. Mikkelsen,et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells , 2007, Nature.
[40] R. Maldonado,et al. Regulation of PI3K/Akt/GSK‐3 pathway by cannabinoids in the brain , 2007, Journal of neurochemistry.
[41] M. Grunstein,et al. Functions of site-specific histone acetylation and deacetylation. , 2007, Annual review of biochemistry.
[42] S. Hersch,et al. Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. , 2007, Human molecular genetics.
[43] Dustin E. Schones,et al. High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.
[44] Anton J. Enright,et al. Requirement of bic/microRNA-155 for Normal Immune Function , 2007, Science.
[45] Yi Zhang,et al. Regulation of histone methylation by demethylimination and demethylation , 2007, Nature Reviews Molecular Cell Biology.
[46] A. Carracedo,et al. Cannabinoids Induce Glioma Stem-like Cell Differentiation and Inhibit Gliomagenesis* , 2007, Journal of Biological Chemistry.
[47] Gratien G. Prefontaine,et al. Histone Methylation-Dependent Mechanisms Impose Ligand Dependency for Gene Activation by Nuclear Receptors , 2007, Cell.
[48] Keji Zhao,et al. Genome-wide prediction of conserved and nonconserved enhancers by histone acetylation patterns. , 2006, Genome research.
[49] Suresh Cuddapah,et al. The genomic landscape of histone modifications in human T cells , 2006, Proceedings of the National Academy of Sciences.
[50] Henriette O'Geen,et al. Suz12 binds to silenced regions of the genome in a cell-type-specific manner. , 2006, Genome research.
[51] Jun S. Song,et al. CEAS: cis-regulatory element annotation system , 2006, Nucleic Acids Res..
[52] J. Zeitlinger,et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells , 2006, Nature.
[53] S. Bell,et al. Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. , 2006, Molecular human reproduction.
[54] Megan F. Cole,et al. Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.
[55] James A. Cuff,et al. A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.
[56] G. Blobel,et al. Histone H3 Lysine 9 Methylation and HP1γ Are Associated with Transcription Elongation through Mammalian Chromatin. , 2005 .
[57] M. Hung,et al. Akt-Mediated Phosphorylation of EZH2 Suppresses Methylation of Lysine 27 in Histone H3 , 2005, Science.
[58] G. Blobel,et al. Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. , 2005, Molecular cell.
[59] Tony Kouzarides,et al. Spatial Distribution of Di- and Tri-methyl Lysine 36 of Histone H3 at Active Genes* , 2005, Journal of Biological Chemistry.
[60] J. O’Shea,et al. Discrete Roles for Histone Acetylation in Human T Helper 1 Cell-specific Gene Expression* , 2004, Journal of Biological Chemistry.
[61] M. Nagarkatti,et al. Activation through Cannabinoid Receptors 1 and 2 on Dendritic Cells Triggers NF-κB-Dependent Apoptosis: Novel Role for Endogenous and Exogenous Cannabinoids in Immunoregulation1 , 2004, The Journal of Immunology.
[62] Wei Zhang,et al. Cannabinoid receptor‐mediated regulation of intracellular calcium by Δ9‐tetrahydrocannabinol in resting T cells , 2004, Journal of leukocyte biology.
[63] M. Roth,et al. Δ9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells , 2002, Journal of Neuroimmunology.
[64] D. Halbert,et al. T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. , 2002, Cellular immunology.
[65] W. Tam. Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. , 2001, Gene.
[66] R. Ronca,et al. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. , 2000, Blood.
[67] Shu-Hsia Chen,et al. Gr-1+ Myeloid Cells Derived from Tumor-Bearing Mice Inhibit Primary T Cell Activation Induced Through CD3/CD28 Costimulation1 , 2000, The Journal of Immunology.
[68] Li Zhu,et al. Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway1 , 2000, The Journal of Immunology.
[69] C. Newton,et al. Δ9-Tetrahydrocannabinol Treatment Suppresses Immunity and Early IFN-γ, IL-12, and IL-12 Receptor β2 Responses to Legionella pneumophila Infection1 , 2000, The Journal of Immunology.
[70] T. Klein,et al. Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1. , 1998, The Journal of pharmacology and experimental therapeutics.
[71] S. Galiègue,et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. , 1995, European journal of biochemistry.
[72] C. Newton,et al. Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection , 1994, Infection and immunity.
[73] P. Casellas,et al. Cannabinoid-receptor expression in human leukocytes. , 1993, European journal of biochemistry.
[74] G. Cutler,et al. Marijuana: interaction with the estrogen receptor. , 1983, The Journal of pharmacology and experimental therapeutics.
[75] M. Schlumpf,et al. Delta(9)-tetrahydrocannabinol Inhibits 17β-Estradiol-induced Proliferation and Fails to Activate Androgen and Estrogen Receptors in MCF7 Human Breast Cancer Cells , 2008 .
[76] B. Kamińska,et al. Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein. , 2005, Cellular signalling.
[77] M. Guenther,et al. Biochemical isolation and analysis of a nuclear receptor corepressor complex. , 2003, Methods in enzymology.
[78] Li Zhu,et al. D-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway , 2000 .